• S&P 500: 1,338.83
  • Change: -0.97%
$1.39 -0.04 (-2.80%)
2/10/2012 10:39 AM

China Sky One Medical (NASDAQ:CSKI)

CAPS Rating: 3 out of 5

The company develops, manufactures, markets, and sells over-the-counter, branded nutritional supplements, and over-the-counter plant- and herb-based pharmaceuticals primarily in China.

Current Price $1.39 Mkt Cap $23.55M
Open $1.42 P/E Ratio 1.40
Prev. Close $1.43 Div. (Yield) N/A (N/A)
Daily Range $1.39 - $1.44 Volume 5,125
52-Wk Range $0.89 - $5.91 Avg. Daily Vol. 0

News & Discussion Boards

Caps

This ticker is not currently Ratable.

All Players

552 Outperform
42 Underperform
 

All-Star Players

128 Outperform
15 Underperform
 

Wall Street

1 Outperform
0 Underperform
 

Top CSKI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

AaronRogers (81.38)
Submitted April 29, 2011

This is a throw the baby out with the bath water stock. The hero is the fireman who catches the little one. The SEC has announced investigation and to date nothing. The leaders of this company have commented on this and have been adament that there… More

2 Comments | Reply | Report this Post

BuffettJunior1 (95.02)
Submitted October 28, 2011

Chinese reverse merger fraud.

Add Comment | Reply | Report this Post
CSKI VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about CSKI.

Recs

1
Member Avatar BuffettJunior1 (95.02) Submitted: 10/28/2011 3:29:22 PM : Underperform Start Price: $1.95 CSKI Score: +32.99

Chinese reverse merger fraud.

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar DavidBear (< 20) Submitted: 8/4/2011 11:38:20 AM : Outperform Start Price: $2.96 CSKI Score: -62.70

CSKI seems to be real. At this price its a value.

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar tilbud (< 20) Submitted: 7/4/2011 2:26:09 PM : Outperform Start Price: $2.12 CSKI Score: -34.52

CSKI has been the target of relentless short attacks that are based on wild distortions. Of course the company has some problems, as do the strongest companies in the U.S. But it also has outstanding metrics and shows great promise in extending its business beyond traditional Chinese medicines. It is a well run company and its success is sure to be recognized by institutional investors and quite possibly by international drug manufacturers seeking a cost effective entry into the vast Chinese market.

Report this Post Add Comment | Reply | Permalink
View All 76 Pitches »

Leaderboard

Find the members with the highest scoring picks in CSKI.

Score Leader

Alain988

Alain988 (< 20) Score: +143.32

The Score Leader is the player with the highest score across all their picks in CSKI.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		Index
Gain 		Score Commentary
Alain988 < 20 5/4/2009 Underperform 1Y $14.67 -90.52% +53.03% +143.56 0 Comment
DavisFreeberg 46.37 5/15/2009 Underperform 5Y $14.14 -90.17% +51.92% +142.09 0 Comment
unstoppablepeon < 20 10/27/2008 Underperform NS $6.87 -79.77% +59.08% +138.84 0 Comment
tcss007 96.57 6/12/2009 Underperform 5Y $16.76 -91.71% +43.55% +135.25 0 Comment
DrRetardles 33.61 8/17/2009 Underperform 5Y $14.93 -90.69% +36.64% +127.33 0 Comment
Secksuality 28.21 9/14/2009 Underperform 5Y $13.55 -89.74% +29.72% +119.46 0 Comment
obsoleteaccount 90.94 7/2/2010 Underperform 5Y $11.00 -87.36% +29.86% +117.22 0 Comment
pcoppney < 20 10/13/2009 Underperform 1Y $13.88 -89.98% +24.86% +114.84 1 Comment
Infantryman11 < 20 12/2/2009 Underperform 3W $17.10 -91.87% +20.33% +112.20 0 Comment
MarginCallMcW < 20 12/2/2009 Underperform 3W $17.10 -91.87% +20.33% +112.20 0 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackVanDenBerg 95.05 6/10/2009 Outperform 1Y $17.60 -92.10% +41.93% -134.03 1 Comment
TrackJGreenblatt 85.22 10/14/2008 Outperform 1Y $9.79 +42.19% +3.56% +38.62 10/14/2009 @ $13.92 2 Comments

Featured Broker Partners